Keurig Dr Pepper beats expectations despite Q4 impairment
Keurig Dr Pepper has booked Q4 results that beat analyst estimates despite the US group recording a $718m impairment for the period.

Feb 28, 2025 0
Feb 28, 2025 0
Feb 28, 2025 0
Feb 23, 2025 0
Feb 23, 2025 0
Feb 28, 2025 0
Feb 28, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 27, 2025 0
Feb 27, 2025 0
Feb 27, 2025 0
Feb 27, 2025 0
Feb 26, 2025 0
Or register with email
Feb 9, 2025 0
Feb 10, 2025 0
Feb 11, 2025 0
Feb 9, 2025 0
Feb 21, 2025 0
Feb 13, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.